Medicare Enrolled
Dr. Gregory Scott, M.D.
Neurology · St Petersburg, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Scott from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Scott?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Scott
Dr. Gregory Scott is a neurology specialist in St Petersburg, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Scott performed 2,087 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Scott received a total of $16,291 from 72 pharmaceutical and/or device companies across 909 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Scott is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 20% volume in FL
$16,291 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,087
Medicare services
Top 20% in FL for neurology
Not available
Unique patients (not deduplicated)
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Physical therapy exercise, per 15 min A therapy session using exercises to improve strength, endurance, range of motion, and flexibility. Each 15-minute unit is billed separately. |
691 | $20 | $65 |
| Manual therapy (hands-on treatment), per 15 min | 425 | $16 | $42 |
| Electrical stimulation therapy, per 15 minutes Application of electrical stimulation to the body with a therapist present. The service is billed for each 15-minute increment of treatment. |
339 | $9 | $30 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
275 | $90 | $200 |
| Additional hour of neuropsychological test evaluation This code covers the evaluation of neuropsychological testing for each additional hour beyond the initial service. It represents the time spent analyzing and interpreting test results. |
89 | $77 | $202 |
| New patient office visit, complex (60-74 min) | 78 | $158 | $412 |
| Additional 30 minutes of psychological or neuropsychological testing This code represents an additional 30-minute increment for administering psychological or neuropsychological tests. It is used to bill for time beyond the initial testing period. |
65 | $30 | $85 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
41 | $139 | $292 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
19 | $69 | $200 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
19 | $101 | $266 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
18 | $25 | $70 |
| Evaluation for physical therapy, typically 20 minutes | 16 | $74 | $170 |
| Psychological or neuropsychological test, first 30 minutes Administration of psychological or neuropsychological testing for the first 30 minutes. |
12 | $33 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$16,291
Total received (2018-2024)
Avg $2,327/year across 7 years
Top 19% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
909
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,492
2023
$3,029
2022
$2,890
2021
$1,606
2020
$526
2019
$2,616
2018
$2,131
Payments by company (2024)
ABBVIE INC.
$319
PFIZER INC.
$307
ARGENX US, INC.
$266
Alexion Pharmaceuticals, Inc.
$243
Lilly USA, LLC
$206
Novartis Pharmaceuticals Corporation
$202
Biogen, Inc.
$195
Lundbeck LLC
$158
Takeda Pharmaceuticals U.S.A., Inc.
$137
Azurity Pharmaceuticals, Inc.
$129
GE HEALTHCARE
$127
Neurocrine Biosciences, Inc.
$126
SCILEX PHARMACEUTICALS INC.
$116
Otsuka America Pharmaceutical, Inc.
$113
EMD Serono, Inc.
$113
Celgene Corporation
$102
ACADIA Pharmaceuticals Inc
$93
Vanda Pharmaceuticals Inc.
$67
UCB, Inc.
$64
Eisai Inc.
$61
Amgen Inc.
$54
Merz Pharmaceuticals, LLC
$48
Sumitomo Pharma America, Inc.
$46
Acorda Therapeutics, Inc
$42
Kyowa Kirin, Inc.
$39
MDD US Operations, LLC
$38
SK Life Science, Inc.
$33
TG Therapeutics, Inc.
$27
Amneal Pharmaceuticals LLC
$20
Top 3 companies account for 25.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,231
GENZYME CORPORATION
$941
UCB, Inc.
$780
EMD Serono, Inc.
$713
Biogen, Inc.
$664
Lilly USA, LLC
$640
ABBVIE INC.
$615
ACADIA Pharmaceuticals Inc
$608
Amgen Inc.
$595
ARGENX US, INC.
$571
Alexion Pharmaceuticals, Inc.
$518
PFIZER INC.
$514
Neurocrine Biosciences, Inc.
$510
Lundbeck LLC
$469
Teva Pharmaceuticals USA, Inc.
$455
AbbVie Inc.
$392
Takeda Pharmaceuticals U.S.A., Inc.
$382
Acorda Therapeutics, Inc
$325
Allergan Inc.
$317
Janssen Pharmaceuticals, Inc
$282
Supernus Pharmaceuticals, Inc.
$268
Celgene Corporation
$224
MDD US Operations, LLC
$182
Electromed, Inc.
$180
Otsuka America Pharmaceutical, Inc.
$178
Avanir Pharmaceuticals, Inc.
$178
Sunovion Pharmaceuticals Inc.
$175
Amneal Pharmaceuticals LLC
$172
Azurity Pharmaceuticals, Inc.
$171
Allergan, Inc.
$168
Biohaven Pharmaceutical Holding Company Ltd.
$147
ARBOR PHARMACEUTICALS, INC.
$131
Sumitomo Pharma America, Inc.
$130
Horizon Therapeutics plc
$130
Biohaven Pharmaceuticals, Inc.
$129
GE HEALTHCARE
$127
GE HealthCare
$126
SCILEX PHARMACEUTICALS INC.
$116
US WorldMeds, LLC
$111
Adamas Pharmaceuticals, Inc.
$108
Kyowa Kirin, Inc.
$108
Bayer HealthCare Pharmaceuticals Inc.
$104
Genentech USA, Inc.
$103
Merz North America, Inc.
$100
CSL Behring
$95
Eisai Inc.
$94
GE Healthcare
$81
BANNER LIFE SCIENCES, LLC
$73
UPSHER-SMITH LABORATORIES LLC
$73
Banner Life Sciences, LLC
$70
Vanda Pharmaceuticals Inc.
$67
Mitsubishi Tanabe Pharma America, Inc.
$65
SK Life Science, Inc.
$64
Arbor Pharmaceuticals, Inc.
$58
Merz Pharmaceuticals, LLC
$48
SANOFI-AVENTIS U.S. LLC
$45
TG THERAPEUTICS, INC.
$38
AbbVie, Inc.
$38
Corium, LLC
$33
Zyla Life Sciences
$32
CATALYST PHARMACEUTICALS, INC.
$29
TG Therapeutics, Inc.
$27
Grifols USA, LLC
$26
Catalyst Pharmaceuticals, Inc.
$23
Assertio Therapeutics, Inc.
$21
Abbott Laboratories
$17
Upsher-Smith Laboratories LLC
$17
Mallinckrodt Enterprises LLC
$16
Vertical Pharmaceuticals, LLC
$15
MERZ NORTH AMERICA, INC.
$15
Medtronic USA, Inc.
$14
Impax Laboratories, Inc.
$11
Top 3 companies account for 18.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COMIRNATY · COPAXONE · Cambia · DUOPA · Duopa · EMGALITY · FIRDAPSE · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Gocovri · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · OXTELLAR XR · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · POMPE - DISEASE · PONVORY · Ponvory · QULIPTA · RELEXXII · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SKYCLARYS · SMARTVEST · SOLIRIS · SPRIX · Solitaire · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XADAGO · XCOPRI · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
170
County median income
$70,293
Nearest hospital to ZIP centroid (approximate)
ORLANDO HEALTH BAYFRONT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Scott is a clinical cardiology specialist, with above-average Medicare volume (top 20% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Scott experienced with physical therapy exercise, per 15 min?
Based on Medicare claims data, Dr. Scott performed 691 physical therapy exercise, per 15 min services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Scott receive payments from pharmaceutical companies?
Yes. Dr. Scott received a total of $16,291 from 72 companies across 909 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Scott's costs compare to other neurologists in St Petersburg?
Dr. Scott's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Scott) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in St Petersburg
Browse neurologists in St Petersburg ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology